FDA Approves EVEROLIMUS — Natco Pharma Limited

# FDA Approves Generic Everolimus from Natco Pharma Natco Pharma Limited received FDA approval for its generic version of everolimus, an oral immunosuppressant and cancer therapeutic, potentially expanding market access and driving cost savings for patients requiring this treatment. The approval of the generic formulation is expected to increase competition in the everolimus market and could pressure pricing for the original branded product.